Literature DB >> 14550954

Overexpression of Reg IV in colorectal adenoma.

Yuwei Zhang1, Maode Lai, Bingjian Lv, Xuemei Gu, Huiping Wang, Yimin Zhu, Yangli Zhu, Lina Shao, Guofeng Wang.   

Abstract

Identification of molecular markers associated with colorectal adenoma may uncover critical events involved in the initiation and progression of colorectal cancer. Our previous studies, mainly based on suppression subtractive hybridization, have identified Reg IV as a strong candidate for a gene that is highly expressed in colorectal adenoma when compared to normal mucosa. In this study, we sought to determine the mRNA expression of Reg IV in colorectal adenoma, in comparison with normal colorectal mucosa and carcinoma in multiple samples. Semi-quantitative RT-PCR was performed in 12 colorectal adenomas and 10 concurrent carcinomas. Reg IV mRNA level was higher in all adenomas (12/12) (p=0.001) and in 9/10 concurrent colorectal carcinoma (p=0.021) when compared to paired normal colorectal mucosa. Northern blot analysis further confirmed these results. In situ hybridization with digoxigenin (DIG)-labeled cRNA was performed in 32 colorectal adenomas with varying degree of dysplasia. Compared with paired normal tissues, Reg IV was overexpressed in 74% (14/19) adenomas with mild or moderate dysplasia and 100% (13/13) cases of adenoma with severe dysplasia. In addition, higher levels of Reg IV mRNA was consistently scored in regions with more severe dysplasia within the same adenoma sample displaying varying degree of dysplasia. The strongest staining was seen within carcinomoutous areas of the 12 adenoma cases (p=0.002). Our results support that overexpression of Reg IV may be an early event in colorectal carcinogenesis. Detection of Reg IV overexpression may be useful in the early diagnosis of carcinomatous transformation of adenoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550954     DOI: 10.1016/s0304-3835(03)00460-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei.

Authors:  Kukka Heiskala; Jill Giles-Komar; Marja Heiskala; Leif C Andersson
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

2.  RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor.

Authors:  Feng-ying Li; Xiao-bin Ren; En-ping Xu; Qiong Huang; Hong-qiang Sheng; Bing-jian Lv; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

Review 3.  Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers.

Authors:  Masakatsu Numata; Takashi Oshima
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

4.  Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.

Authors:  Kumar S Bishnupuri; Satheesh K Sainathan; Kislay Bishnupuri; Devon R Leahy; Qizhi Luo; Shrikant Anant; Courtney W Houchen; Brian K Dieckgraefe
Journal:  Mol Carcinog       Date:  2013-10-22       Impact factor: 4.784

5.  Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.

Authors:  Li-Sha Ying; Jiang-Liu Yu; Xiao-Xiao Lu; Zhi-Qiang Ling
Journal:  Dig Dis Sci       Date:  2012-09-26       Impact factor: 3.199

6.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

Review 7.  Reg gene family and human diseases.

Authors:  Yu-Wei Zhang; Liu-Song Ding; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 8.  The Potential Role of REG Family Proteins in Inflammatory and Inflammation-Associated Diseases of the Gastrointestinal Tract.

Authors:  Chao Sun; Xiaoyu Wang; Yangyang Hui; Hirokazu Fukui; Bangmao Wang; Hiroto Miwa
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

9.  Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Authors:  Qi Wang; Jianping Deng; Jun Yuan; Liang Wang; Zhenwei Zhao; Shiming He; Yongsheng Zhang; Yanyang Tu
Journal:  Diagn Pathol       Date:  2012-06-19       Impact factor: 2.644

10.  The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

Authors:  Aude Legoffic; Ezequiel Calvo; Carla Cano; Emma Folch-Puy; Marc Barthet; Jean Robert Delpero; Montse Ferrés-Masó; Jean Charles Dagorn; Daniel Closa; Juan Iovanna
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.